Medical specialists from France tagged as investigators in clinical trials studying Lymphoma, B-Cell
Total 65 results
-
Adrian TempesculSeen in:
- Other, Brest Cedex, Centre Hospitalier Regional Universitaire (CHRU) Brest - Hopital Morvan
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Antoine Bonnet, MDSeen in:
- Vannes, Ch de Bretagne Atlantique -
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
Bernard DRENOU, MDSeen in:
- Mulhouse, Gh Region Mulhouse Et Sud Alsace
- Mulhouse, Hematology Unit CH E.MULLER
Trials:- NCT01976182 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions: -
Bertrand JolySeen in:
- Other, Corbeil-Essonnes, Centre Hospitalier Sud Francilien
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Borhane Slama, MDSeen in:
- Avignon, CH d'Avignon
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
Caroline Serrier, MDSeen in:
- Other, Perpignan CEDEX, Centre Hospitalier de Perpignan
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Catherine RIOUFOL, Pharm DSeen in:
- Pierre-Bénite, Service pharmaceutique, Hospices Civils de Lyon - Groupement Hospitalier Sud
Trials:- NCT05532761 (Principal Investigator)
-
Catherine THIEBLEMONT, MD PhDSeen in:
- Paris, Hôpital Saint louis
Trials:- NCT04703686 (Principal Investigator)
-
Charles Herbaux, PhDSeen in:
- Montpellier, CHU de Montpellier
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
Cristina CASTILLA LLORENTESeen in:
- Villejuif, Institut de Cancerologie Gustave Roussy
Trials:- NCT04531046 (Principal Investigator)
Conditions: -
Elsa LESTANG, MDSeen in:
- Saint-Nazaire, CH Saint Nazaire
- Saint-Nazaire, Centre Hospitalier de St Nazaire
Trials:- NCT05298293 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions: -
Emmanuel Bachy, PhDSeen in:
- Pierre Bénite, Emmanuel Bachy
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
Fabien Le Bras, MDSeen in:
- Créteil, Hôpital Henri Mondor
Trials:- NCT04703686 (Principal Investigator)
-
Fontanet BijouSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux, Institut Bergonie
- Other, Bordeaux, Centre de Lutte Contre le Cancer (CLCC) - Institut Bergonie
Trials:- NCT04662255 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT03869619 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions:- Lymphoma, Mantle-Cell;
- Diffuse Large B-cell Lymphoma;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Mantle Cell Lymphoma (MCL);
- Follicular Lymphoma (FL);
- Diffuse Large B Lymphoma (DLBCL);
- Marginal Zone Lymphoma (MZL);
- T-cell Lymphoma (T-NHL);
- Hodgkin's Lymphoma (HL);
- Burkitt Lymphoma (BL));
- Lymphoma, B-Cell
-
FRANCK MORSCHHAUSER, MDSeen in:
- Lille, CHRU LILLE - Hôpital Claude Huriez
- Lille, CHRU Lille
- Lille, Hopital Claude Huriez
- Lille, Hopital Claude Huriez; Hematologie
- Lille, Service des Maladies du Sang - CHRU de Lille
Trials:- NCT04531046 (Principal Investigator)
- NCT05529524 (Principal Investigator)
- NCT04703686 (Principal Investigator)
- NCT04446962 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions:- B-cell Lymphoma Recurrent;
- B-Cell Lymphoma Refractory;
- Follicular Lymphoma;
- Refractory Indolent Adult Non-Hodgkin Lymphoma;
- Refractory Mantle Cell Lymphoma;
- Diffuse Large B-Cell Lymphoma Refractory;
- Refractory Transformed B-cell Non-Hodgkin Lymphoma;
- Refractory Primary Mediastinal Large B-Cell Cell Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Lymphoma, B-Cell
-
François Lemonnier, DoctorSeen in:
- Créteil, François Lemonnier
Trials:- NCT04842877 (Principal Investigator)
Conditions: -
François X Gros, MDSeen in:
- Pessac, Chu de Bordeaux - Hopital Haut Leveque
Trials:- NCT04703686 (Principal Investigator)
-
François-Xavier GROSSeen in:
- Bordeaux, Chu de Bordeaux - Hopital Haut Leveque
- Pessac, CHU de Bordeaux - Hopital Haut-Lévêque
Trials:- NCT04531046 (Principal Investigator)
- NCT05444712 (Principal Investigator)
-
Frédéric MALOISEL, MDSeen in:
- Strasbourg, Centre de radiothérapie de Robertsau
Trials:- NCT05298293 (Principal Investigator)
Conditions: -
Frédéric PEYRADE, MDSeen in:
- Nice, Centre Lacassagne
- Other, Nice Cedex 2, Centre de Lutte contre le Cancer (CLCC) - Centre Antoine Lacassagne
Trials:- NCT04404283 (Principal Investigator)
- NCT04446962 (Principal Investigator)
-
Gian Matteo Pica, MDSeen in:
- Chambéry, CH de Chambery
- Chambéry, Ch Metropole Savoie - Site Chambery
Trials:- NCT02889523 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions: -
Gian PicaSeen in:
- Other, Chambery, Centre Hospitalier Metropole Savoie - Chambery
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Guillaume Cartron, MDSeen in:
- Cedex 05, Montpellier, CHU de Montpellier
- Montpellier, CH Saint-Eloi
- Montpellier, CHU Montpellier
- Montpellier, CHU Saint Eloi; Service d'Hématologie Clinique
- Montpellier, Département d'hématologie clinique
- Montpellier, Hematogy Unit CHU ST ELOI
- Montpellier, Hopital Saint Eloi
Trials:- NCT01976182 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04531046 (Principal Investigator)
- NCT05529524 (Principal Investigator)
- NCT06006117 (Principal Investigator)
- NCT04703686 (Principal Investigator)
- NCT04290000 (Principal Investigator)
Conditions:- Large Granular Lymphocytes Leukemia;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- B-cell Lymphoma Recurrent;
- B-Cell Lymphoma Refractory;
- Follicular Lymphoma;
- Refractory Indolent Adult Non-Hodgkin Lymphoma;
- Refractory Mantle Cell Lymphoma;
- Diffuse Large B-Cell Lymphoma Refractory;
- Refractory Transformed B-cell Non-Hodgkin Lymphoma;
- Refractory Primary Mediastinal Large B-Cell Cell Lymphoma;
- Lymphoma and Acute Lymphoblastic Leukemia
-
Herve Ghesquieres, MDSeen in:
- Other, Pierre-Benite Cedex, Centre Hospitalier Lyon Sud
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Hervé Tilly, MD PhDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT04703686 (Principal Investigator)
-
Jacques O Bay, MDSeen in:
- Clermont Ferrand, CHU de Clermont Ferrand
Trials:- NCT04703686 (Principal Investigator)
Clinical Trials on Lymphoma, B-Cell
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Australia, Taiwan
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Lymphoma, B-Cell | B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Curocell Inc.RecruitingHigh-grade B-cell Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Transformed Follicular Lymphoma (TFL) | Refractory Large B-cell Lymphoma | Relapsed Large B-cell LymphomaKorea, Republic of
-
Massachusetts General HospitalVarian Medical SystemsRecruitingLymphoma, B-Cell | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Lymphoma | High-grade B-cell Lymphoma | Relapsed Cancer | Mediastinal Large B-cell LymphomaUnited States
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States